STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 15, n. 6, p. 764–769, 2023. DOI: 10.25004/IJPSDR.2023.150610. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/8011.. Acesso em: 17 oct. 2025.